Delia Goletti

Latest

• Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
• Risk assessment of tuberculosis in immunocompromised patients. A TBNET study
• Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement